SANUWAVE Health (SNWV) Cash & Equivalents (2010 - 2026)

SANUWAVE Health (SNWV) has reported Cash & Equivalents for 17 consecutive years, with $9.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 10.36% year-over-year to $9.4 million in Q2 2026; TTM through Jun 2026 was $9.4 million, a 10.36% increase from a year earlier, with the FY2025 full-year figure at $12.0 million, up 16.82% from the prior year.
• Cash & Equivalents was $9.4 million for Q2 2026 at SANUWAVE Health, down from $10.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $12.0 million in Q4 2025 and troughed at $106000.0 in Q1 2023.
• A 5-year average of $4.7 million and a median of $2.7 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents slumped 77.63% in 2023 and jumped 2669.81% in 2024, its largest moves.
• Over 5 years, Cash & Equivalents stood at $1.2 million in 2022, then soared by 55.85% to $1.8 million in 2023, then jumped by 469.67% to $10.2 million in 2024, then climbed by 16.82% to $12.0 million in 2025, then retreated by 21.6% to $9.4 million in 2026.
• The last three Cash & Equivalents figures came in at $9.4 million (Q2 2026), $10.8 million (Q1 2026), and $12.0 million (Q4 2025), per Business Quant data.